

Is Azasan still in shortage in 2026? Get the latest update on Azathioprine supply, pricing, and what patients can do to find their medication.
If you take Azasan (Azathioprine) for a transplant, rheumatoid arthritis, or an autoimmune condition, you may have experienced difficulty filling your prescription over the past couple of years. Drug shortages have become an all-too-common reality for patients who rely on essential medications, and Azathioprine has been caught up in this trend.
In this article, we'll give you the latest update on the Azasan and Azathioprine supply situation in 2026, explain what's been happening, and share practical steps you can take to keep your treatment on track.
Here's the current picture as of early 2026:
The bottom line: the injectable form remains in active shortage, while oral tablets (especially the generic) are generally available but may require some extra effort to find at your local pharmacy.
Several factors have contributed to the supply challenges:
Azasan is only made by Salix Pharmaceuticals. When a drug has only one manufacturer, any production disruption — whether from raw material issues, quality control, or regulatory requirements — directly impacts all patients who use the brand.
Azathioprine is used for an expanding list of conditions beyond its two FDA-approved indications. Off-label use for Crohn's disease, ulcerative colitis, lupus, myasthenia gravis, and autoimmune hepatitis has increased overall demand. Meanwhile, the number of organ transplants in the U.S. continues to grow year over year.
When hospitals can't get the injectable form, post-surgical patients are sometimes switched to oral Azathioprine sooner than planned. This increases demand at retail pharmacies and can create localized shortages of oral tablets.
Like many generic medications, Azathioprine relies on a global supply chain for raw ingredients (active pharmaceutical ingredients, or APIs). Disruptions at any point — from API manufacturing overseas to shipping delays — can ripple through to your local pharmacy.
For a deeper dive into these factors, see our article on why Azasan is so hard to find.
Cost can be another barrier for patients, especially if they need to switch between brand and generic or use out-of-pocket options:
Insurance typically covers generic Azathioprine with low copays ($0 to $15 on most plans). Brand-name Azasan may require prior authorization and could have higher out-of-pocket costs. For more savings strategies, read our guide on how to save money on Azasan.
While no new generic Azasan formulations have been introduced recently, patients do have several options:
Here are the most effective steps you can take today:
For a complete walkthrough, read our guide on how to find Azasan in stock near you.
The Azasan supply situation in 2026 is improving but not fully resolved. The injectable form remains in shortage, and the brand-name oral tablets can still be tricky to find at some pharmacies. However, generic Azathioprine is widely available, and with tools like Medfinder, discount coupons, and patient assistance programs, most patients should be able to keep their treatment on track.
The most important takeaway: don't skip doses. If you're having trouble finding your medication, reach out to your doctor, use Medfinder, and explore the resources above. Your health depends on it.
Want to learn more about this medication? Read our articles on what Azasan is, Azasan side effects, and drug interactions to watch for.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.